Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Predictors of accelerated FEV1 decline in adults with airflow limitation-Findings from the Health2006 cohort

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. COPD patients prescribed inhaled corticosteroid in general practice: Based on disease characteristics according to guidelines?

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Antibiotic therapy for stable non-CF bronchiectasis in adults - A systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  1. The unifying diagnostic construct of bodily distress syndrome (BDS) was confirmed in the general population

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Changes in subtypes of overt thyrotoxicosis and hypothyroidism following iodine fortification

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Copeptin, a surrogate marker for arginine vasopressin secretion, is positively associated with glucagon

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

To investigate predictors of accelerated decline in forced expiratory volume in 1 s (FEV1) in individuals with preexisting airflow limitation (AL). Participants in the Health2006 baseline study aged ≥ 35 with FEV1/ forced vital capacity (FVC) < lower limit of normal (LLN) were invited for a 10-year follow-up. At both examinations, data were obtained on demographics, spirometry, fitness level, allergy, and exhaled nitric oxide. We used multiple regression modeling to predict the annual decline in FEV1, reported as regression coefficients ( R) and 95% confidence intervals (CIs). A total of 123 (43% of those invited) participated in the follow-up examination, where more had exercise-induced dyspnea but fewer had asthma symptoms. Being female ( R = -29.8 ml, CI: -39.7 to -19.8), diagnosed with asthma ( R = -13.7, CI: -20.4 to -7.0) or atopic dermatitis ( R = -29.0, CI: -39.7 to -18.4), and having current asthma symptoms or nightly respiratory symptoms ( R = -22.1, CI: -31.9 to -12.4 and R = -14.3, CI: -19.9 to -8.7, respectively) were significantly associated with a steeper decline in FEV1. Although to a smaller extent, a steeper decline was also predicted by age, baseline FEV1, waist/hip-ratio, and number of pack-years smoked. In individuals with preexisting AL, being female and having ever or current respiratory symptoms were associated with an accelerated annual decline in FEV1.

Original languageEnglish
JournalChronic Respiratory Disease
Volume16
ISSN1479-9723
DOIs
Publication statusPublished - 5 Jun 2019

    Research areas

  • Airflow limitation, asthma, chronic obstructive pulmonary disease, lung function decline, respiratory symptoms

ID: 57307056